Janus Henderson Investors US’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$93.1M Sell
1,370,698
-551,205
-29% -$38.8M 0.08% 297
2016
Q4
$138M Sell
1,921,903
-408,801
-18% -$30.4M 0.12% 222
2016
Q3
$184M Sell
2,330,704
-1,465,914
-39% -$119M 0.16% 185
2016
Q2
$317M Sell
3,796,618
-1,405,037
-27% -$125M 0.27% 87
2016
Q1
$478M Buy
5,201,655
+50,545
+1% +$4.56M 0.41% 46
2015
Q4
$521M Sell
5,151,110
-599,009
-10% -$62.3M 0.44% 49
2015
Q3
$565M Buy
5,750,119
+92,845
+2% +$10.3M 0.51% 38
2015
Q2
$662M Sell
5,657,274
-512,296
-8% -$56M 0.54% 32
2015
Q1
$605M Buy
6,169,570
+271,117
+5% +$27.5M 0.5% 37
2014
Q4
$556M Sell
5,898,453
-3,763,065
-39% -$389M 0.48% 44
2014
Q3
$1.03B Sell
9,661,518
-6,355,432
-40% -$622M 0.94% 9
2014
Q2
$1.33B Sell
16,016,950
-5,400,583
-25% -$420M 1.22% 5
2014
Q1
$1.52B Buy
21,417,533
+2,151,048
+11% +$169M 1.41% 3
2013
Q4
$1.45B Sell
19,266,485
-195,787
-1% -$13.6M 1.36% 5
2013
Q3
$1.22B Buy
19,462,272
+222,772
+1% +$13.3M 1.21% 6
2013
Q2
$985M Buy
+19,239,500
New +$1B 1.03% 10

Other funds holding GILD

Janus Henderson Investors US's GILD Position: Q1 2017 in Review

Janus Henderson Investors US reduced its Gilead Sciences (GILD) stake by 29% in Q1 2017, selling an estimated $38.8M and leaving 1,370,698 shares worth $93.1M. The position accounts for 0.08% of the portfolio, ranked #297.

Janus Henderson Investors US first reported a position in GILD in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.52B in Q1 2014. 1,525 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Janus Henderson Investors US held 1,370,698 shares of Gilead Sciences worth $93.1M as of Q1 2017.
  • Janus Henderson Investors US sold 551,205 Gilead Sciences shares in Q1 2017, an estimated $38.8M.
  • Gilead Sciences made up 0.08% of Janus Henderson Investors US's portfolio in Q1 2017, its #297 holding.
  • Janus Henderson Investors US first reported a position in Gilead Sciences in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Gilead Sciences position peaked at $1.52B in Q1 2014.
  • 1,525 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.